Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "Efficacy & Safety Outcomes With Pembro Rechallenge for Patients With Advanced/Metastatic Urothelial Cancer Who Responded to First-Course Treatment"

188 views
November 15, 2023
Comments 0
Login to view comments. Click here to Login